Five considerations to help organizations make better planning and forecasting decisions in an environment with such strict parameters.
Familiarize yourself with the new FDA draft guidance on blood pressure response which carries important implications for drug developers.
How the use of tools can enable your objective of ensuring patient safety by having the right amount of material available with an appropriate investment in inventory cost.
With spiraling costs and increasing stakeholder demands, it’s critical that studies get off to the right start.
Workflow-based technology coupled with executive authoritative power encourages process optimization in the clinical trial continuum, helping to break down silos, enhance operational performance and ensure quality in the electronic trial master file.
How to employ processes that take an upfront approach to preventing or mitigating problems associated with document completion.
Why you should prepare now even with nearly a year remaining.
Since the launch of myTI—TransPerfect’s mobile experience for the Trial Interactive eTMF—I have heard rave reviews from clinical operations leaders and CRAs. The advantages of mobile technology for clinical operations are generating a lot of excitement, and rightfully so. In my collaboration with study teams during the development, release, and ongoing evolution of myTI, we encountered many thematic pain points that were ripe for a mobile solution.
An overview of the progress that has been made in pediatric drug development.
Look at ways to proactively recruit so as to overcome challenges.
|
|
|
|
|
|
|
|
|